Scholarlink

<p>The current management of end-stage liver diseases relies on organ transplantation but is constrained by donor scarcity and immune rejection. Induced pluripotent stem cell (iPSC)-derived cells represent a promising alternative, as they can be expanded indefinitely, genome-edited to reduce immunogenicity and employed to develop more mature three-dimensional cultures. Here, we combined tissue engineering with hypoimmunogenic iPSC technology to generate off-the-shelf hepatic organoids that integrate parenchymal and non-parenchymal cells: hepatocytes, cholangiocytes, hepatic stellate cells, Kupffer cells and both vascular and sinusoidal endothelial cells. Lineage identity was validated by gene and protein expression analysis, electron microscopy and single-cell RNA sequencing. The complex microenvironment obtained recapitulates native liver composition and promotes hepatic maturation, as evidenced by the secretion of liver-specific proteins, including albumin and apolipoproteins. These properties, together with the presence of a functional endothelial network, represent a step towards universal cell therapies for end-stage liver diseases and hepatic metabolic disorders.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Hypoimmunogenic iPSC-derived hepatic organoids featuring a functional vascular network

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月24日

查看全文
  • Annalina Caroli,
  • Marco Varinelli,
  • Laura Vigani,
  • Arianna Vallerga,
  • Paola Rizzo,
  • Daniela Rottoli,
  • Sara Conti,
  • Ilaria Craparotta,
  • Stefano Fumagalli,
  • Giuseppe Remuzzi,
  • Ariela Benigni,
  • Susanna Tomasoni,
  • Piera Trionfini

摘要

The current management of end-stage liver diseases relies on organ transplantation but is constrained by donor scarcity and immune rejection. Induced pluripotent stem cell (iPSC)-derived cells represent a promising alternative, as they can be expanded indefinitely, genome-edited to reduce immunogenicity and employed to develop more mature three-dimensional cultures. Here, we combined tissue engineering with hypoimmunogenic iPSC technology to generate off-the-shelf hepatic organoids that integrate parenchymal and non-parenchymal cells: hepatocytes, cholangiocytes, hepatic stellate cells, Kupffer cells and both vascular and sinusoidal endothelial cells. Lineage identity was validated by gene and protein expression analysis, electron microscopy and single-cell RNA sequencing. The complex microenvironment obtained recapitulates native liver composition and promotes hepatic maturation, as evidenced by the secretion of liver-specific proteins, including albumin and apolipoproteins. These properties, together with the presence of a functional endothelial network, represent a step towards universal cell therapies for end-stage liver diseases and hepatic metabolic disorders.